The beneficial effects of G2-SUISO against hepatic steatosis in NASH elderly rats may be exerted through the inhibition of lipogenesis pathways by reducing SREBP-1c, ACC and FAS expression, thereby causing a reduction in the hepatic fat accumulation and a significant decrease in TC levels in serum. This evidence concerns the gene FAS and metabolic dysfunction-associated steatohepatitis.